Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Frequently asked questions
What sector does Devyser Diagnostics AB (DVYSR) operate in?
Devyser Diagnostics AB belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Devyser Diagnostics AB (DVYSR) current stock price?
As of the latest data, Devyser Diagnostics AB stock price is SEK 50.40, with a previous close of SEK 51.00. Devyser Diagnostics AB lost -SEK 0.60 in the last trading session, representing a -1.18% loss.
What is Devyser Diagnostics AB (DVYSR) current market capitalization?
Devyser Diagnostics AB market cap is approximately 851.25 million.
What is Devyser Diagnostics AB (DVYSR) Earnings Per Share (EPS)?
The trailing EPS is SEK 0.92, and the forward EPS is SEK 1.29.
What is Devyser Diagnostics AB (DVYSR) Price-to-Earnings (P/E) ratio?
Devyser Diagnostics AB current P/E ratio is 54.78, with a forward P/E of 39.21.
What is Devyser Diagnostics AB (DVYSR) EBITDA?
Devyser Diagnostics AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 9.80 million.
Does Devyser Diagnostics AB (DVYSR) pay dividends?
No. Devyser Diagnostics AB does not pay a dividend.
How did Devyser Diagnostics AB (DVYSR) perform in its most recent earnings report?
In the last report (June 30, 2026), Devyser Diagnostics AB posted an EPS surprise of -74.07% and a revenue surprise of 0%.
When is Devyser Diagnostics AB (DVYSR) next earnings report?
Devyser Diagnostics AB is expected to release its next earnings report on September 30, 2026.
What is Devyser Diagnostics AB (DVYSR) beta (volatility) score?
Devyser Diagnostics AB has a beta of 0.781, indicating lower volatility than the overall market.
